Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterisation of TLR4+ Blood Cells in Solid Cancer
NCT06131775Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2024
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoints: Progression-Free Survival at 24 months and Percentage of TLR4+ cells in peripheral blood at 6 months. Started May 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06131775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06131775.